Skip to main content
Equibles
ALGS logo

ALGS · Aligos Therapeutics, Inc. · Short Interest

Track ALGS — free

Use ALGS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALGS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.98 -0.18 (-8.33%) At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Nov 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our recurring losses from operations and negative cash flows raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Nov 6, 2026
Market Cap
$7.10M
Shares
3.59M
Volume · Nov 12 120.58K Avg daily vol (3M) 55.63K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

ALGS Latest Reported Short Interest

FINRA reported 677,218 ALGS shares sold short as of the October 30, 2026 settlement date, a decrease of 30,253 shares. Days to cover was 20.77 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

ALGS Short Interest Forecast

Equibles' model estimates 660,056 shares sold short for the November 13, 2026 settlement, -2.5% versus the latest reported position, with a likely range of 521,252 to 805,182 shares. This model prediction uses FINRA data through November 12, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 12 Low confidence 47% chance it rises
660,056 -2.5% vs reported
Likely range 521,252 to 805,182 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
70/100
Short interest 18.9% of shares — P97 Days to cover 20.8 — P97 Price vs VWAP -61.4% — P3 Short-volume trend -0.4% — P52 Short interest change -4.3% — P38 Worst FTD 0.57% of shares — P94

Positioning score 70.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-13 07:05 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-30 Scheduled
    FINRA publishes Dec 9
    		 — — — —
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 677,218 707,471 -30,253 20.77
    2026-10-15 707,471 708,744 -1,273 21.74
    2026-09-30 708,744 697,683 +11,061 14.35
    2026-09-15 697,683 648,568 +49,115 15.35
    2026-08-31 648,568 568,056 +80,512 9.41
    2026-08-14 568,056 606,525 -38,469 2.71
    2026-07-31 606,525 521,416 +85,109 6.39
    2026-07-15 521,416 543,337 -21,921 1.01
    2026-06-30 543,337 611,712 -68,375 7.94
    2026-06-15 611,712 576,909 +34,803 6.13
    2026-05-29 576,909 535,177 +41,732 4.75
    2026-05-15 535,177 489,633 +45,544 3.45
    2026-04-30 489,633 275,689 +213,944 1.00
    2026-04-15 275,689 306,176 -30,487 4.55
    2026-03-31 306,176 294,842 +11,334 7.59
    2026-03-13 294,842 289,814 +5,028 6.45
    2026-02-27 289,814 288,715 +1,099 11.57
    2026-02-13 288,715 293,582 -4,867 5.37
    2026-01-30 293,582 268,943 +24,639 3.46
    2026-01-15 268,943 240,691 +28,252 3.58
    2025-12-31 240,691 258,242 -17,551 4.70
    2025-12-15 258,242 226,418 +31,824 2.91
    2025-11-28 226,418 233,534 -7,116 2.77
    2025-11-14 233,534 227,276 +6,258 2.91

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1799448 CUSIP 01626L204 13F (30d) 18 filings 12 filers Visit website Investor relations